Repository corticotropin injection as an alternative treatment for refractory ocular mucous membrane pemphigoid

Yael Sharon, Stephen D. Anesi, Christine E. Martinez, Andrew J.W. Huang, Charles Stephen Foster, David S. Chu

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose:The purpose of this study was to report the clinical course and outcome of patients with refractory ocular mucous membrane pemphigoid (MMP) treated by repository corticotropin injection (RCI).Methods:Patients with biopsy-proven ocular MMP treated with RCI from 3 tertiary medical centers were evaluated. Medical records between January 2013 and January 2021 were reviewed and deidentified to retrieve relevant disease-related data. Primary outcome measures included conjunctival inflammatory activity, change in Foster clinical conjunctival scarring staging after RCI treatment, and the development of ocular and systemic complications.Results:Included were 15 patients (10 women and 5 men; 36-95 yrs of age) with a mean follow-up of 4.5 years. Most of the patients (80%) had Foster stage 3 at presentation, and all patients had active MMP. Each patient had failed to respond to at least 1 immunomodulatory drug during the follow-up, and 9 (60%) patients had treatment failure of at least 2 other agents before the use of RCI. The mean duration of RCI treatment was 21 months (range, 3-54 mo). Foster stage did not change in any of the 15 patients at the last follow-up. Nine patients continued RCI therapy at the last follow-up, and in all of them, the disease activity of MMP was well controlled. No serious adverse events because of RCI were documented during the follow-up in any treated patient.Conclusions:RCI may serve as an alternative or an adjunctive treatment in patients with severe and refractory ocular MMP. Treatment with RCI seems to be safe and well-tolerated.

Original languageEnglish
Pages (from-to)45-51
Number of pages7
JournalCornea
Volume41
Issue number1
DOIs
StatePublished - Jan 1 2022

Keywords

  • Cicatricial conjunctivitis
  • Corticotropin
  • Mucous membrane pemphigoid
  • Ocular surface disease
  • Refractory

Fingerprint

Dive into the research topics of 'Repository corticotropin injection as an alternative treatment for refractory ocular mucous membrane pemphigoid'. Together they form a unique fingerprint.

Cite this